Showing results (101-110 of 412) with videos related to

Sort By:
Pageof 42
Clinical Nuclear Medicine|April 2, 2014
18F-FDG PET/CT in tumefactive multiple sclerosisAnna Margherita Maffione, Lucia Rampin, Gaia Grassetto, et al.
Journal of Nuclear Medicine Technology|November 17, 2007
Reconstruction parameters for 111In-pentetreotide SPECT: variability with respect to body weight and body regionArianna Massaro, Silvia Cittadin, Francesca Rossi, et al.
Nuclear Medicine Communications|April 2, 2014
Are PREDIST criteria better than PERCIST criteria as a PET predictor of preoperative treatment response in rectal cancer?Anna Margherita Maffione, Maria Cristina Marzola, Gaia Grassetto, et al.
Clinical Nuclear Medicine|February 6, 2018
False-Positive 18F-FDG PET/CT Due to Filgrastim That Induced Extramedullary Liver Hematopoiesis in a Burkitt LymphomaAnna Margherita Maffione, Lucia Rampin, Paolini Rossella, et al.
Clinical Nuclear Medicine|June 20, 2020
Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?Anna Margherita Maffione, Giampaolo Montesi, Paola Caroli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2011
The sentinel node procedure in breast cancer: nuclear medicine as the starting pointElif Hindié, David Groheux, Isabelle Brenot-Rossi, et al.
Nuclear Medicine Communications|March 12, 2011
Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancerPaolo Castellucci, Chiara Fuccio, Maria Cristina Marzola, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 16, 2012
Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?Valentina Ambrosini, Davide Campana, Cristina Nanni, et al.
Pageof 42